Livforsakringsbolaget Skandia Omsesidigt Grows Position in Astera Labs, Inc. $ALAB

Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 166.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,400 shares of the company’s stock after purchasing an additional 1,500 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Astera Labs were worth $263,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Reflection Asset Management bought a new stake in shares of Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC increased its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Hilltop National Bank lifted its position in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Aventura Private Wealth LLC purchased a new position in Astera Labs during the 4th quarter valued at about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the fourth quarter worth about $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 2,037,724 shares of company stock valued at $507,157,341. 10.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. JPMorgan Chase & Co. raised their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $275.75.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $350.62 on Thursday. The stock has a market capitalization of $60.10 billion, a PE ratio of 236.91, a price-to-earnings-growth ratio of 4.07 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $88.73 and a 52-week high of $499.48. The company has a 50-day simple moving average of $344.76 and a two-hundred day simple moving average of $218.93.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 1.88 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.